Bronchorrhea, a Rare and Debilitating Symptom of Lung Cancer: Case Report and Review of the Treatment.

JTO Clin Res Rep

Department of Pulmonary and Critical Care Medicine, University of Tennessee, Knoxville, Tennessee.

Published: October 2022

AI Article Synopsis

Article Abstract

Bronchorrhea, defined as production of voluminous watery sputum greater than 100 mL/d, is a debilitating symptom mostly found in end-stage lung cancer, specifically in invasive mucinous adenocarcinomas. Very rarely, it can primarily contribute to hypoxic respiratory failure and found in a critical care setting. We report a case of a 51-year-old woman diagnosed with having mucinous adenocarcinoma of the lung who presented to the intensive care unit with rapidly worsening respiratory failure and found to have massive bronchorrhea with daily sputum volume exceeding 1000 mL/d at its peak. With the limited quantity and quality of evidence available for the treatment of this condition, multiple agents were tried without considerable benefit. We discuss the pathogenesis of this condition and the different treatment options that can be used for palliation of the sputum volume.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508333PMC
http://dx.doi.org/10.1016/j.jtocrr.2022.100398DOI Listing

Publication Analysis

Top Keywords

debilitating symptom
8
lung cancer
8
respiratory failure
8
sputum volume
8
bronchorrhea rare
4
rare debilitating
4
symptom lung
4
cancer case
4
case report
4
report review
4

Similar Publications

Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), is increasingly recognized as a condition affecting not only adults but also children and adolescents. While children often experience milder acute COVID-19 symptoms compared to adults, some develop persistent physical, psychological, and neurological symptoms lasting for weeks or months after initial infection. The most commonly reported symptoms include debilitating fatigue, respiratory issues, headaches, muscle pain, gastrointestinal disturbances, and cognitive difficulties, which significantly impact daily activities, schooling, and social interactions.

View Article and Find Full Text PDF

The Role of the Gastrointestinal Microbiota in Parkinson's Disease.

Biomolecules

December 2024

Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Background/objectives: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons leading to debilitating motor and non-motor symptoms. Beyond its well-known neurological features, emerging evidence underscores the pivotal role of the gut-brain axis and gastrointestinal microbiota in PD pathogenesis. Dysbiosis has been strongly linked to PD and is associated with increased intestinal permeability, chronic inflammation, and the production of neurotoxic metabolites that may exacerbate neuronal damage.

View Article and Find Full Text PDF

Background/objectives: (ALS), or Lou Gehrig's disease, is a debilitating, incurable neurodegenerative disorder characterised by motor neuron death in the spinal cord, brainstem, and motor cortex. With an incidence rate of about 4.42 cases per 100,000 people annually, ALS severely impacts motor function and quality of life, causing progressive muscle atrophy, spasticity, paralysis, and eventually death.

View Article and Find Full Text PDF

Journey of Hope for Patients with Fibromyalgia: From Diagnosis to Self-Management-A Qualitative Study.

Healthcare (Basel)

January 2025

Optometry Department, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.

Background/objectives: Fibromyalgia syndrome (FMS) is a chronic, debilitating condition characterized by widespread pain, fatigue, and psychological distress. There is a lack of qualitative studies on the unique experiences of patients with FMS in Arab countries, particularly through social media. Despite the availability of diagnostic criteria, diagnosing and managing patients remains challenging.

View Article and Find Full Text PDF

Tumor Markers in Pleural Fluid: A Comprehensive Study on Diagnostic Accuracy.

Diagnostics (Basel)

January 2025

Department of General and Clinical Pathology, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.

: Malignant pleural effusions (MPEs) pose a significant challenge in clinical practice and exert a considerable socio-economic burden on the healthcare system, affecting approximately 1 million individuals annually. These effusions are a leading cause of debilitating dyspnea and a diminished quality of life among cancer patients, with distant metastasis to the pleural layers occurring in about 20% of cases during treatment. : A cross-sectional, observational case-control study was conducted on 151 Bulgarian patients with a hydrothorax.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!